2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline activated by the inflammatory response forms nucleotide adducts

Food and Chemical Toxicology

Volumn 43, Issue 11, 2005, Pages 1607-1617

  Lakshmi, Vijaya M ^a   Schut, Herman A J ^b   Zenser, Terry V ^a,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

2 nitrosoamino 3 methylimidazo 4,5 f quinoline; Colon cancer; Genotoxicity; Heterocyclic amines; Inflammation; Nucleotide adducts

Indexed keywords

2 HYDROXYAMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 NITROSOAMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; DEOXYGUANOSINE DERIVATIVE; HYPOCHLOROUS ACID; N (DEOXYGUANOSIN 8 YL) 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; NUCLEASE; NUCLEOTIDE DERIVATIVE; PHOSPHORUS 32; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CANCER RISK; COLITIS; COLON CANCER; COMPARATIVE STUDY; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; ISOTOPE LABELING; OXIDATION; PH;

ASPERGILLUS NUCLEASE S1; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANINE NUCLEOTIDES; DNA ADDUCTS; HYDROLYSIS; INFLAMMATION MEDIATORS; MUTAGENS; NUCLEOTIDES; OXIDATION-REDUCTION; PERCHLORIC ACID; QUINOLINES;

EID: 24644442224     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.05.002     Document Type: Article

References (67)

1. R.H. Adamson, U. Thorgeirsson, E.G. Snyderwine, S.S. Thorgeirsson, J. Reeves, D. Dalgard, S. Takayama, and T. Sugimura Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques Jpn. J. Cancer Res. 81 1990 10 14
2. S. Ambs, W.P. Bennett, W.G. Merriam, M.O. Ogunfusika, S.M. Oser, A.M. Harrington, P.G. Shields, E. Felley-Bosco, S.P. Hussain, and C.C. Harris Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer J. Natl. Cancer Inst. 91 1999 86 88
3. K. Augustsson, K. Skog, M. Jagerstad, P.W. Dickman, and G. Steineck Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study Lancet 353 1999 703 707
4. N. Battula, H.A. Schut, and S.S. Thorgeirsson Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA-adduct formation of aromatic amine carcinogens in NIH 3T3 cells Mol. Carcinog. 4 1991 407 414
5. A.R. Boobis, A.M. Lynch, S. Murray, R. De La Torre, A. Solans, M. Farre, J. Segura, N.J. Gooderham, and D.S. Davies CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans Cancer Res. 54 1994 89 94
6. M.L. Brennan, W. Wu, X. Fu, Z. Shen, W. Song, H. Frost, C. Vadseth, L. Narine, E. Lenkiewicz, M.T. Borchers, A.J. Lusis, J.J. Lee, N.A. Lee, H.M. Abu-Soud, H. Ischiropoulos, and S.L. Hazen A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species J. Biol. Chem. 277 2002 17415 17427
7. R.E. Bryant, A.L. Rashad, J.A. Mazza, and D. Hammond β-Lactamase activity in human pus J. Infect. Dis. 142 1980 594 601
8. C.A. Bunton, and B.B. Wolfe Decomposition of pyridine-2- and -4-diazoates J. Am. Chem. Soc. 96 1974 3267 3275
9. S.M. Cohen Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay Toxicol. Sci. 80 2004 225 229
10. D.A. Cummings, and H.A.J. Schut Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat Carcinogenesis 15 1994 2623 2628
11. G. Dijkstra, H. Moshage, H.M. Van Dullemen, A. De Jager-Krikken, A.T.M.G. Tiebosch, J.H. Kleibeuker, P.L.M. Jansen, and H. VanGoor Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease J. Pathol. 186 1998 416 421
12. R.J. Dubos The micro-environment of inflammation or Metchnikoff revisited Lancet 269 1955 1 5
13. H. Endo, H.A.J. Schut, and E.G. Snyderwine Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in the supF shuttle vector system Cancer Res. 54 1994 3745 3751
14. J.S. Felton, and M.G. Knize Heterocyclic-amine mutagens/carcinogens in foods C.S. Cooper P.L. Grover Handbook of experimental pharmacology 1990 Springer-Verlag Berlin 471 502
15. J.C. Fuscoe, R. Wu, N.H. Shen, S.K. Healy, and J.S. Felton Base-change analysis of revertants of the hisD3052 allele in Salmonella typhimurium Mutat. Res. 201 1988 241 251
16. M.B. Grisham, D. Jourd'Heuil, and D.A. Wink Nitric oxide - I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation Am. J. Physiol. 39 1999 G315 G321
17. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts Carcinogenesis (London) 3 1982 1081 1092
18. N. Harpaz, and I.C. Talbot Colorectal cancer in idiopathic inflammation bowel disease Semin. Diagn. Pathol. 13 1996 339 357
19. S.P. Hussain, P. Amstad, K. Raja, S. Ambs, M. Nagashima, W.P. Bennett, P.G. Shields, A.-J. Ham, J.A. Swenberg, A.J. Marrogi, and C.C. Harris Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Res. 60 2000 3333 3337
20. M. Jaiswal, N.F. LaRusso, N. Nishioka, Y. Nakabeppu, and G.J. Gores Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide Cancer Res. 61 2001 6388 6393
21. A.J. Kettle, and C.C. Winterbourn Myeloperoxidase: a key regulator of neutrophil oxidant production Redox Rep. 3 1997 3 15
22. E. Kristiansen, O. Meyer, and I. Thorup The ability of two cooked food mutagens to induce aberrant crypt foci in mice Eur. J. Cancer Prev. 6 1997 53 57
23. V.M. Lakshmi, F.F. Hsu, and T.V. Zenser Nitrosation and nitration of 2-amino-3-methylimidazo[4,5-f]quinoline by reactive nitrogen oxygen species Chem. Res. Toxicol. 15 2002 1059 1068
24. V.M. Lakshmi, F.F. Hsu, and T.V. Zenser 2-Nitrosoamino-3-methylimidazo[4, 5-f]quinoline stability and reactivity Chem. Res. Toxicol. 17 2004 709 716
25. V.M. Lakshmi, M.L. Clapper, W.-C. Chang, and T.V. Zenser Hemin potentiates nitric oxide-mediated nitrosation of 2-amino-3-methylimidazo[4,5-f] quinoline to 2-nitrosoamino-3-methylimidazo[4,5-f]quinoline Chem. Res. Toxicol. 18 2005 528 535
26. V.M. Lakshmi, W.M. Nauseef, and T.V. Zenser Myeloperoxidase potentiates nitric oxide-mediated nitrosation J. Biol. Chem. 280 2005 1746 1753
27. 6-alkylguanine-DNA alkyltransferase after reaction with nitric oxide Cancer Res. 62 2002 3037 3043
28. T.M. Marwood, D. Meyer, and P.D. Josephy Escherichia coli lacZ strains engineered for detection of frameshift mutations induced by aromatic amines and nitroaromatic compounds Carcinogenesis 16 1995 2037 2043
29. J.A. Miller Carcinogenesis by chemicals: an overview - G.H.A. Clowes memorial lecture Cancer Res. 30 1970 559 576
30. J.A. Miller, and E.C. Miller The concept of reactive electrophilic metabolites in chemical carcinogenesis: recent results with aromatic amines, safrole, and aflatoxin B1 D.J. Jollow J.J. Kocsis R. Snyder H. Vainio Biological reactive intermediates 1977 Plenum Publishing Corp. New York 6 24
31. S.S. Mirvish Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyneal and bladder cancer and contribution to cancer of known exposures to NOC Cancer Lett. 93 1995 17 48
32. M. Monshouwer, R.A. McLellan, E. Delaporte, R.F. Witkamp, A.S. van Miert, and K.W. Renton Differential effect of pentoxifylline on lipopolysaccharide- induced downregulation of cytochrome P450 Biochem. Pharmacol. 52 1996 1195 1200
33. E.T. Morgan Regulation of cytochromes P450 during inflammation and infection Drug Metab. Rev. 29 2003 1129 1188
34. L.D. Morrison, T.E. Eling, and P.D. Josephy Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3- methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ Mutat. Res. 302 1993 45 52
35. M. Novak, M.J. Kahley, E. Eiger, J.S. Helmick, and H.E. Peters Reactivity and selectivity of nitrenium ions derived from ester derivatives of carcinogenic N-(4-biphenylyl)hydroxylamine and the corresponding hydroxamic acid J. Am. Chem. Soc. 115 1993 9453 9460
36. M. Novak, K. Toth, S. Rajagopal, M. Brooks, L.L. Hott, and M. Moslener Reactivity and selectivity of the N-acetyl-Glu-P-1, N-acetyl-Glu-P-2, N-acetyl-MeIQx, and N-acetyl-IQx nitrenium ions: comparison to carbocyclic N-arylnitrenium ions J. Am. Chem. Soc. 124 2002 7972 7981
37. H. Ohgaki, K. Kusama, N. Matsukura, K. Morino, H. Hasegawa, S. Sato, S. Takayama, and T. Sugimura Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract Carcinogenesis 5 1984 921 924
38. P. Pais, C.P. Salmon, M.G. Knize, and J.S. Felton Formation of mutagenic/carcinogenic heterocyclic amines in dry-heated model systems, meats, and meat drippings J. Agric. Food Chem. 47 1999 1098 1108
39. J. Parsonnet Microbes and malignancy J. Parsonnet Infection as a cause of human cancer 1999 Oxford University Press New York
40. T.E. Paton, and K.W. Renton Cytokine-mediated down-regulation of CYP1A1 in Hepa1 cells Biochem. Pharmacol. 55 1998 1791 1796
41. 32P-postlabeling test for structurally diverse DNA adducts Carcinogenesis 7 1986 1543 1551
42. H.A. Schut, and E.G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis 20 1999 353 368
43. H.A.J. Schut, and C.R. Herzog Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats Cancer Lett. 67 1992 117 124
44. I.I. Singer, D.W. Kawka, S. Scott, J.R. Weidner, R.A. Mumford, T.E. Riehl, and W.F. Stenson Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease Gastroenterology 111 1996 871 885
45. R. Sinha, M. Kulldorff, W.H. Chow, J. Denobile, and N. Rothman Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas Cancer Epidemiol. Biomarkers Prev. 10 2001 559 562
46. E.G. Snyderwine, P.P. Roller, R.H. Adamson, S. Sato, and S.S. Thorgeirsson Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3- methylimidazolo[4,5-f]quinoline with DNA. Synthesis and identification of N-(deoxyguanosin-8-yl)-IQ Carcinogenesis 9 1988 1061 1065
47. E.G. Snyderwine, P.J. Wirth, P.P. Roller, R.H. Adamson, S. Sato, and S.S. Thorgeirsson Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline Carcinogenesis 9 1988 411 418
48. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys Carcinogenesis 14 1993 1389 1395
49. J. Stadler, J. Trockfeld, W.A. Schmalix, T. Brill, J.R. Siewert, H. Greim, and J. Doehmer Inhibition of cytochromes P4501A by nitric oxide Proc. Natl. Acad. Sci. USA 91 1994 3559 3563
50. T. Sugimura Nutrition and dietary carcinogens Carcinogenesis 21 2000 387 395
51. T. Suzuki, T. Nakamura, M. Yamada, H. Ide, K. Kanaori, K. Tajima, T. Morii, and K. Makino Isolation and characterization of diazoate intermediate upon nitrous acid and nitric oxide treatment of 2′-deoxycytidine Biochemistry 38 1999 7151 7158
52. T. Suzuki, M. Yamada, T. Nakamura, H. Ide, K. Kanaori, K. Tajima, T. Morii, and K. Makino Products of the reaction between a diazoate derivative of 2′-deoxycytidine and l-lysine and its implication for DNA-nucleoprotein cross-linking by NO or HNO(2) Chem. Res. Toxicol. 13 2000 1223 1227
53. M. Takahashi, T. Minamoto, T. Sugimura, and H. Esumi High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline Carcinogenesis 14 1993 1355 1357
54. 2 atoms of guanine Chem. Res. Toxicol. 5 1992 479 490
55. R.J. Turesky, A. Constable, J. Richoz, N. Varga, J. Markovic, M.V. Martin, and F.P. Guengerich Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2 Chem. Res. Toxicol. 11 1998 925 936
56. A. van der Vliet, J.P. Eiserich, B. Halliwell, and C.E. Cross Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite J. Biol. Chem. 272 1997 7617 7625
57. R. Vuppugalla, and R. Mehvar Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers J. Pharmacol. Exp. Ther. 310 2004 718 727
58. K. Wakabayashi, M. Nagao, H. Esumi, and T. Sugimura Food-derived mutagens and carcinogens Cancer Res. 52 suppl 1992 2092s 2098s
59. D. Wild, and G.H. Degen Prostaglandin H synthase dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type Carcinogenesis 8 1987 541 545
60. J.A. Williams, E.M. Stone, B.C. Millar, B.A. Gusterson, P.L. Grover, and D.H. Phillips Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast Pharmacogenetics 8 1998 519 528
61. J.A. Williams, E.M. Stone, B.C. Millar, A. Hewer, and D.H. Phillips Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts Mutagenesis 15 2000 149 154
62. D.A. Wink, Y. Osawa, J.F. Darbyshire, C.R. Jones, S.C. Eshenaur, and R.W. Nims Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent Arch. Biochem. Biophys. 300 1993 115 123
63. E. Wolz, W. Pfau, and G.H. Degen Bioactivation of the food mutagen 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) by prostaglandin-H synthase and by monooxygenases: DNA adduct analysis Food Chem. Toxicol. 38 2000 513 522
64. M. Yamashita, K. Wakabayashi, M. Nagao, S. Sato, Z. Yamaizumi, M. Takahashi, N. Kinae, L. Tomita, and T. Sugimura Detection of 2-amino-3-methylimidazo[4,5-f]quinoline in cigarette smoke condensate Jpn. J. Cancer Res. 77 1986 419 422
65. Y. Yamazoe, D.W. Miller, C.C. Weis, K.L. Dooley, T.V. Zenser, F.A. Beland, and F.F. Kadlubar DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo Carcinogenesis 6 1985 1379 1387
66. T.V. Zenser, V.M. Lakshmi, F.F. Hsu, and B.B. Davis Peroxygenase metabolism of N-acetylbenzidine by prostaglandin H synthase J. Biol. Chem. 274 1999 14850 14856
67. H. Zollinger Diazo chemistry I: aromatic and heteroaromatic compounds 1994 VCH Weinheim Germany pp. 59-90